4-[[1-(cyclobutylmethyl)benzimidazol-2-yl]amino]-N-hydroxybenzamide;4-[(1-cyclopropylbenzimidazol-2-yl)amino]-N-hydroxybenzamide;4-[[1-(cyclopropylmethyl)benzimidazol-2-yl]amino]-N-hydroxybenzamide;4-[[1-(4,4-difluorocyclohexyl)benzimidazol-2-yl]amino]-N-hydroxybenzamide;N-hydroxy-4-[[1-(1-methylpiperidin-4-yl)benzimidazol-2-yl]amino]benzamide;N-hydroxy-4-[[1-(2-methylpropyl)benzimidazol-2-yl]amino]benzamide

C112H117F2N25O12 — CID 158678885

IUPAC4-[[1-(cyclobutylmethyl)benzimidazol-2-yl]amino]-N-hydroxybenzamide;4-[(1-cyclopropylbenzimidazol-2-yl)amino]-N-hydroxybenzamide;4-[[1-(cyclopropylmethyl)benzimidazol-2-yl]amino]-N-hydroxybenzamide;4-[[1-(4,4-difluorocyclohexyl)benzimidazol-2-yl]amino]-N-hydroxybenzamide;N-hydroxy-4-[[1-(1-methylpiperidin-4-yl)benzimidazol-2-yl]amino]benzamide;N-hydroxy-4-[[1-(2-methylpropyl)benzimidazol-2-yl]amino]benzamide
SMILESCC(C)Cn1c(Nc2ccc(C(=O)NO)cc2)nc2ccccc21.CN1CCC(n2c(Nc3ccc(C(=O)NO)cc3)nc3ccccc32)CC1.O=C(NO)c1ccc(Nc2nc3ccccc3n2C2CC2)cc1.O=C(NO)c1ccc(Nc2nc3ccccc3n2C2CCC(F)(F)CC2)cc1.O=C(NO)c1ccc(Nc2nc3ccccc3n2CC2CC2)cc1.O=C(NO)c1ccc(Nc2nc3ccccc3n2CC2CCC2)cc1
InChIInChI=1S/C20H20F2N4O2.C20H23N5O2.C19H20N4O2.C18H18N4O2.C18H20N4O2.C17H16N4O2/c21-20(22)11-9-15(10-12-20)26-17-4-2-1-3-16(17)24-19(26)23-14-7-5-13(6-8-14)18(27)25-28;1-24-12-10-16(11-13-24)25-18-5-3-2-4-17(18)22-20(25)21-15-8-6-14(7-9-15)19(26)23-27;24-18(22-25)14-8-10-15(11-9-14)20-19-21-16-6-1-2-7-17(16)23(19)12-13-4-3-5-13;23-17(21-24)13-7-9-14(10-8-13)19-18-20-15-3-1-2-4-16(15)22(18)11-12-5-6-12;1-12(2)11-22-16-6-4-3-5-15(16)20-18(22)19-14-9-7-13(8-10-14)17(23)21-24;22-16(20-23)11-5-7-12(8-6-11)18-17-19-14-3-1-2-4-15(14)21(17)13-9-10-13/h1-8,15,28H,9-12H2,(H,23,24)(H,25,27);2-9,16,27H,10-13H2,1H3,(H,21,22)(H,23,26);1-2,6-11,13,25H,3-5,12H2,(H,20,21)(H,22,24);1-4,7-10,12,24H,5-6,11H2,(H,19,20)(H,21,23);3-10,12,24H,11H2,1-2H3,(H,19,20)(H,21,23);1-8,13,23H,9-10H2,(H,18,19)(H,20,22)
InChIKeyIEWDXRJZZLAXDF-UHFFFAOYSA-N
MW2043.33 g/mol
LogP21.61
Rot. Bonds27

About 4-[[1-(cyclobutylmethyl)benzimidazol-2-yl]amino]-N-hydroxybenzamide;4-[(1-cyclopropylbenzimidazol-2-yl)amino]-N-hydroxybenzamide;4-[[1-(cyclopropylmethyl)benzimidazol-2-yl]amino]-N-hydroxybenzamide;4-[[1-(4,4-difluorocyclohexyl)benzimidazol-2-yl]amino]-N-hydroxybenzamide;N-hydroxy-4-[[1-(1-methylpiperidin-4-yl)benzimidazol-2-yl]amino]benzamide;N-hydroxy-4-[[1-(2-methylpropyl)benzimidazol-2-yl]amino]benzamide

4-[[1-(cyclobutylmethyl)benzimidazol-2-yl]amino]-N-hydroxybenzamide;4-[(1-cyclopropylbenzimidazol-2-yl)amino]-N-hydroxybenzamide;4-[[1-(cyclopropylmethyl)benzimidazol-2-yl]amino]-N-hydroxybenzamide;4-[[1-(4,4-difluorocyclohexyl)benzimidazol-2-yl]amino]-N-hydroxybenzamide;N-hydroxy-4-[[1-(1-methylpiperidin-4-yl)benzimidazol-2-yl]amino]benzamide;N-hydroxy-4-[[1-(2-methylpropyl)benzimidazol-2-yl]amino]benzamide (PubChem CID 158678885) has the molecular formula C112H117F2N25O12 and a molecular weight of 2043.33 g/mol. Its IUPAC name is 4-[[1-(cyclobutylmethyl)benzimidazol-2-yl]amino]-N-hydroxybenzamide;4-[(1-cyclopropylbenzimidazol-2-yl)amino]-N-hydroxybenzamide;4-[[1-(cyclopropylmethyl)benzimidazol-2-yl]amino]-N-hydroxybenzamide;4-[[1-(4,4-difluorocyclohexyl)benzimidazol-2-yl]amino]-N-hydroxybenzamide;N-hydroxy-4-[[1-(1-methylpiperidin-4-yl)benzimidazol-2-yl]amino]benzamide;N-hydroxy-4-[[1-(2-methylpropyl)benzimidazol-2-yl]amino]benzamide.

Molecular Properties

Compound Name4-[[1-(cyclobutylmethyl)benzimidazol-2-yl]amino]-N-hydroxybenzamide;4-[(1-cyclopropylbenzimidazol-2-yl)amino]-N-hydroxybenzamide;4-[[1-(cyclopropylmethyl)benzimidazol-2-yl]amino]-N-hydroxybenzamide;4-[[1-(4,4-difluorocyclohexyl)benzimidazol-2-yl]amino]-N-hydroxybenzamide;N-hydroxy-4-[[1-(1-methylpiperidin-4-yl)benzimidazol-2-yl]amino]benzamide;N-hydroxy-4-[[1-(2-methylpropyl)benzimidazol-2-yl]amino]benzamide
PubChem CID158678885
Molecular FormulaC112H117F2N25O12
Molecular Weight2043.33 g/mol
Exact Mass2041.93
IUPAC Name4-[[1-(cyclobutylmethyl)benzimidazol-2-yl]amino]-N-hydroxybenzamide;4-[(1-cyclopropylbenzimidazol-2-yl)amino]-N-hydroxybenzamide;4-[[1-(cyclopropylmethyl)benzimidazol-2-yl]amino]-N-hydroxybenzamide;4-[[1-(4,4-difluorocyclohexyl)benzimidazol-2-yl]amino]-N-hydroxybenzamide;N-hydroxy-4-[[1-(1-methylpiperidin-4-yl)benzimidazol-2-yl]amino]benzamide;N-hydroxy-4-[[1-(2-methylpropyl)benzimidazol-2-yl]amino]benzamide
SMILESCC(C)Cn1c(Nc2ccc(C(=O)NO)cc2)nc2ccccc21.CN1CCC(n2c(Nc3ccc(C(=O)NO)cc3)nc3ccccc32)CC1.O=C(NO)c1ccc(Nc2nc3ccccc3n2C2CC2)cc1.O=C(NO)c1ccc(Nc2nc3ccccc3n2C2CCC(F)(F)CC2)cc1.O=C(NO)c1ccc(Nc2nc3ccccc3n2CC2CC2)cc1.O=C(NO)c1ccc(Nc2nc3ccccc3n2CC2CCC2)cc1
InChIInChI=1S/C20H20F2N4O2.C20H23N5O2.C19H20N4O2.C18H18N4O2.C18H20N4O2.C17H16N4O2/c21-20(22)11-9-15(10-12-20)26-17-4-2-1-3-16(17)24-19(26)23-14-7-5-13(6-8-14)18(27)25-28;1-24-12-10-16(11-13-24)25-18-5-3-2-4-17(18)22-20(25)21-15-8-6-14(7-9-15)19(26)23-27;24-18(22-25)14-8-10-15(11-9-14)20-19-21-16-6-1-2-7-17(16)23(19)12-13-4-3-5-13;23-17(21-24)13-7-9-14(10-8-13)19-18-20-15-3-1-2-4-16(15)22(18)11-12-5-6-12;1-12(2)11-22-16-6-4-3-5-15(16)20-18(22)19-14-9-7-13(8-10-14)17(23)21-24;22-16(20-23)11-5-7-12(8-6-11)18-17-19-14-3-1-2-4-15(14)21(17)13-9-10-13/h1-8,15,28H,9-12H2,(H,23,24)(H,25,27);2-9,16,27H,10-13H2,1H3,(H,21,22)(H,23,26);1-2,6-11,13,25H,3-5,12H2,(H,20,21)(H,22,24);1-4,7-10,12,24H,5-6,11H2,(H,19,20)(H,21,23);3-10,12,24H,11H2,1-2H3,(H,19,20)(H,21,23);1-8,13,23H,9-10H2,(H,18,19)(H,20,22)
InChIKeyIEWDXRJZZLAXDF-UHFFFAOYSA-N
XLogP21.61
TPSA478.32 Ų
H-Bond Donors18
H-Bond Acceptors31
Rotatable Bonds27
Heavy Atoms151
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002043.33
LogP ≤ 521.61
H-Bond Donors ≤ 518
H-Bond Acceptors ≤ 1031

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'hydroxamic_acid', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}

Analyze 4-[[1-(cyclobutylmethyl)benzimidazol-2-yl]amino]-N-hydroxybenzamide;4-[(1-cyclopropylbenzimidazol-2-yl)amino]-N-hydroxybenzamide;4-[[1-(cyclopropylmethyl)benzimidazol-2-yl]amino]-N-hydroxybenzamide;4-[[1-(4,4-difluorocyclohexyl)benzimidazol-2-yl]amino]-N-hydroxybenzamide;N-hydroxy-4-[[1-(1-methylpiperidin-4-yl)benzimidazol-2-yl]amino]benzamide;N-hydroxy-4-[[1-(2-methylpropyl)benzimidazol-2-yl]amino]benzamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 4-[[1-(cyclobutylmethyl)benzimidazol-2-yl]amino]-N-hydroxybenzamide;4-[(1-cyclopropylbenzimidazol-2-yl)amino]-N-hydroxybenzamide;4-[[1-(cyclopropylmethyl)benzimidazol-2-yl]amino]-N-hydroxybenzamide;4-[[1-(4,4-difluorocyclohexyl)benzimidazol-2-yl]amino]-N-hydroxybenzamide;N-hydroxy-4-[[1-(1-methylpiperidin-4-yl)benzimidazol-2-yl]amino]benzamide;N-hydroxy-4-[[1-(2-methylpropyl)benzimidazol-2-yl]amino]benzamide?
The IUPAC name of 4-[[1-(cyclobutylmethyl)benzimidazol-2-yl]amino]-N-hydroxybenzamide;4-[(1-cyclopropylbenzimidazol-2-yl)amino]-N-hydroxybenzamide;4-[[1-(cyclopropylmethyl)benzimidazol-2-yl]amino]-N-hydroxybenzamide;4-[[1-(4,4-difluorocyclohexyl)benzimidazol-2-yl]amino]-N-hydroxybenzamide;N-hydroxy-4-[[1-(1-methylpiperidin-4-yl)benzimidazol-2-yl]amino]benzamide;N-hydroxy-4-[[1-(2-methylpropyl)benzimidazol-2-yl]amino]benzamide (CID 158678885) is 4-[[1-(cyclobutylmethyl)benzimidazol-2-yl]amino]-N-hydroxybenzamide;4-[(1-cyclopropylbenzimidazol-2-yl)amino]-N-hydroxybenzamide;4-[[1-(cyclopropylmethyl)benzimidazol-2-yl]amino]-N-hydroxybenzamide;4-[[1-(4,4-difluorocyclohexyl)benzimidazol-2-yl]amino]-N-hydroxybenzamide;N-hydroxy-4-[[1-(1-methylpiperidin-4-yl)benzimidazol-2-yl]amino]benzamide;N-hydroxy-4-[[1-(2-methylpropyl)benzimidazol-2-yl]amino]benzamide.
What is the SMILES notation for 4-[[1-(cyclobutylmethyl)benzimidazol-2-yl]amino]-N-hydroxybenzamide;4-[(1-cyclopropylbenzimidazol-2-yl)amino]-N-hydroxybenzamide;4-[[1-(cyclopropylmethyl)benzimidazol-2-yl]amino]-N-hydroxybenzamide;4-[[1-(4,4-difluorocyclohexyl)benzimidazol-2-yl]amino]-N-hydroxybenzamide;N-hydroxy-4-[[1-(1-methylpiperidin-4-yl)benzimidazol-2-yl]amino]benzamide;N-hydroxy-4-[[1-(2-methylpropyl)benzimidazol-2-yl]amino]benzamide?
The canonical SMILES for 4-[[1-(cyclobutylmethyl)benzimidazol-2-yl]amino]-N-hydroxybenzamide;4-[(1-cyclopropylbenzimidazol-2-yl)amino]-N-hydroxybenzamide;4-[[1-(cyclopropylmethyl)benzimidazol-2-yl]amino]-N-hydroxybenzamide;4-[[1-(4,4-difluorocyclohexyl)benzimidazol-2-yl]amino]-N-hydroxybenzamide;N-hydroxy-4-[[1-(1-methylpiperidin-4-yl)benzimidazol-2-yl]amino]benzamide;N-hydroxy-4-[[1-(2-methylpropyl)benzimidazol-2-yl]amino]benzamide is CC(C)Cn1c(Nc2ccc(C(=O)NO)cc2)nc2ccccc21.CN1CCC(n2c(Nc3ccc(C(=O)NO)cc3)nc3ccccc32)CC1.O=C(NO)c1ccc(Nc2nc3ccccc3n2C2CC2)cc1.O=C(NO)c1ccc(Nc2nc3ccccc3n2C2CCC(F)(F)CC2)cc1.O=C(NO)c1ccc(Nc2nc3ccccc3n2CC2CC2)cc1.O=C(NO)c1ccc(Nc2nc3ccccc3n2CC2CCC2)cc1.
What is the InChIKey of 4-[[1-(cyclobutylmethyl)benzimidazol-2-yl]amino]-N-hydroxybenzamide;4-[(1-cyclopropylbenzimidazol-2-yl)amino]-N-hydroxybenzamide;4-[[1-(cyclopropylmethyl)benzimidazol-2-yl]amino]-N-hydroxybenzamide;4-[[1-(4,4-difluorocyclohexyl)benzimidazol-2-yl]amino]-N-hydroxybenzamide;N-hydroxy-4-[[1-(1-methylpiperidin-4-yl)benzimidazol-2-yl]amino]benzamide;N-hydroxy-4-[[1-(2-methylpropyl)benzimidazol-2-yl]amino]benzamide?
The InChIKey is IEWDXRJZZLAXDF-UHFFFAOYSA-N. The full InChI is InChI=1S/C20H20F2N4O2.C20H23N5O2.C19H20N4O2.C18H18N4O2.C18H20N4O2.C17H16N4O2/c21-20(22)11-9-15(10-12-20)26-17-4-2-1-3-16(17)24-19(26)23-14-7-5-13(6-8-14)18(27)25-28;1-24-12-10-16(11-13-24)25-18-5-3-2-4-17(18)22-20(25)21-15-8-6-14(7-9-15)19(26)23-27;24-18(22-25)14-8-10-15(11-9-14)20-19-21-16-6-1-2-7-17(16)23(19)12-13-4-3-5-13;23-17(21-24)13-7-9-14(10-8-13)19-18-20-15-3-1-2-4-16(15)22(18)11-12-5-6-12;1-12(2)11-22-16-6-4-3-5-15(16)20-18(22)19-14-9-7-13(8-10-14)17(23)21-24;22-16(20-23)11-5-7-12(8-6-11)18-17-19-14-3-1-2-4-15(14)21(17)13-9-10-13/h1-8,15,28H,9-12H2,(H,23,24)(H,25,27);2-9,16,27H,10-13H2,1H3,(H,21,22)(H,23,26);1-2,6-11,13,25H,3-5,12H2,(H,20,21)(H,22,24);1-4,7-10,12,24H,5-6,11H2,(H,19,20)(H,21,23);3-10,12,24H,11H2,1-2H3,(H,19,20)(H,21,23);1-8,13,23H,9-10H2,(H,18,19)(H,20,22).
What are the key properties of 4-[[1-(cyclobutylmethyl)benzimidazol-2-yl]amino]-N-hydroxybenzamide;4-[(1-cyclopropylbenzimidazol-2-yl)amino]-N-hydroxybenzamide;4-[[1-(cyclopropylmethyl)benzimidazol-2-yl]amino]-N-hydroxybenzamide;4-[[1-(4,4-difluorocyclohexyl)benzimidazol-2-yl]amino]-N-hydroxybenzamide;N-hydroxy-4-[[1-(1-methylpiperidin-4-yl)benzimidazol-2-yl]amino]benzamide;N-hydroxy-4-[[1-(2-methylpropyl)benzimidazol-2-yl]amino]benzamide?
4-[[1-(cyclobutylmethyl)benzimidazol-2-yl]amino]-N-hydroxybenzamide;4-[(1-cyclopropylbenzimidazol-2-yl)amino]-N-hydroxybenzamide;4-[[1-(cyclopropylmethyl)benzimidazol-2-yl]amino]-N-hydroxybenzamide;4-[[1-(4,4-difluorocyclohexyl)benzimidazol-2-yl]amino]-N-hydroxybenzamide;N-hydroxy-4-[[1-(1-methylpiperidin-4-yl)benzimidazol-2-yl]amino]benzamide;N-hydroxy-4-[[1-(2-methylpropyl)benzimidazol-2-yl]amino]benzamide has a molecular weight of 2043.33 g/mol, XLogP of 21.61, 27 rotatable bonds, 18 hydrogen bond donors, and 31 hydrogen bond acceptors.
Where does this data come from?
All data for 4-[[1-(cyclobutylmethyl)benzimidazol-2-yl]amino]-N-hydroxybenzamide;4-[(1-cyclopropylbenzimidazol-2-yl)amino]-N-hydroxybenzamide;4-[[1-(cyclopropylmethyl)benzimidazol-2-yl]amino]-N-hydroxybenzamide;4-[[1-(4,4-difluorocyclohexyl)benzimidazol-2-yl]amino]-N-hydroxybenzamide;N-hydroxy-4-[[1-(1-methylpiperidin-4-yl)benzimidazol-2-yl]amino]benzamide;N-hydroxy-4-[[1-(2-methylpropyl)benzimidazol-2-yl]amino]benzamide is sourced from PubChem (CID 158678885), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).